Stansberry Asset Management, LLC Biogen Inc. Transaction History

Stansberry Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3.28 Million - $5.25 Million	-12,663 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $21,136 - $24,762	87 Added 0.69%	12,663 $3.54 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $149,316 - $224,758	632 Added 5.29%	12,576 $3.08 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $3.16 Million - $3.65 Million	11,944 New	11,944 $3.39 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $2.14 Million - $3.02 Million	-8,212 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $2.53 Million - $2.83 Million	8,212	8,212 $2.62 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stansberry Asset Management, LLC with notifications on news.